Kyodo Pharmaceutical announced that recently, Hubei Kyodo Pharmaceutical Research Institute Co., Ltd. (hereinafter referred to as “CNAS”), a wholly-owned subsidiary of Hubei Kyodo Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”), received a laboratory accreditation certificate and accreditation decision from the China National Accreditation Committee for Conformity Assessment (hereinafter referred to as “CNAS”).
共同药业：子公司共同甾体研究收到“CNAS授予的实验室认可证书
Kyodo Pharmaceutical: The subsidiary Kyodo Steroid Research received a “Laboratory Accreditation Certificate from CNAS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.